Become A Part of Hemab
Join us as we work together to give patients with rare clotting disorder a new lifeline and improve health equity around the globe.
Join us as we work together to give patients with rare clotting disorder a new lifeline and improve health equity around the globe.
Hemab is developing targeted prophylactic treatments for bleeding and thrombotic disorders - reimagining the standard of care for patients everywhere.
We are a clinical-stage biotech company developing prophylactic therapeutics for serious bleeding and thrombotic disorders. Based in Cambridge, MA, Hemab is progressing a pipeline of bispecific and monovalent antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need.
Join The Ultimate Clotting Company
While the emergence of prophylactic options has changed the treatment paradigm for patients with blood coagulation disorders such as hemophilia, other less common disorders lack adequate preventative therapies. The tens of thousands of women, men and children with these disorders can face unpredictable, potentially servere bleeding episodes – often in visible or stigmatized locations – that fundamentally restrict their ability to live normal lives.
This devastating combination of life-threatening acute hemorrhages and relentless chronic bleeding may profoundly impact patient's physical health, mental health, and quality of life. We believe our subcutaneous prophylactic therapeutics have the potential to significantly improve the lives of patients.
Let's build the ultimate coagulation company together!
Hemab Therapeutics is developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. Our mission is to build the leading coagulation company by discovering, developing, and commercializing innovative therapies for the millions of patients worldwide suffering from serious coagulation diseases.
Hemab and other biotech companies have recently been made aware of a growing number of email scams targeting job candidates in our industry.
Please note: Hemab will post any legitimate job openings directly on our website (www.hemab.com) and through HiTalento, who hosts our career site.
Furthermore, we do not ask candidates to purchase anything through us or to provide sensitive identifiable information via email. If you wish to verify the legitimacy of a job opening, you may contact us through info@hemab.com and someone from our team will respond directly.